Gesundheit
US-FDA verweigert erneut Zulassung von Supernus-Kombination zur Behandlung von Parkinson
Supernus Pharmaceuticals said the US FDA has refused to approve a drug and device combination to treat Parkinson’s disease’s movement-related symptoms, sending its shares down
Risiko einer Dengue-Epidemie in Argentinien steigt
Mosquitoes are hatching earlier in Argentina and reaching colder regions than before, as rising temperatures drive the country’s worst dengue outbreak. So far in the
Geneos-Krebsimpfstoff lässt Lebertumoren in kleiner Studie schrumpfen
Nearly a third of patients with advanced liver cancer who received a personalised vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a
Synchron bereitet groß angelegten Versuch mit Gehirnimplantaten vor
Synchron is preparing to recruit patients for a large-scale clinical trial needed to gain commercial approval for its device, the company’s chief executive told Reuters.
Novo Nordisk-Muttergesellschaft reicht in den USA erneut Angebot für Catalent-Deal ein
The parent company of Wegovy maker Novo Nordisk has reapplied to the US Federal Trade Commission for approval of a $16.5bn deal to buy manufacturing
US-FDA genehmigt erweiterten Einsatz der Krebszelltherapie von J&J
The US Food and Drug Administration has authorised the expanded use of Johnson & Johnson and Legend Biotech’s Carvicti cell therapy as an early treatment
Das Schizophrenie-Medikament von Bristol Myers lindert Symptome ohne Gewichtszunahme
Bristol Myers Squibb said Saturday that data from late-stage studies of its experimental schizophrenia drug showed it helps reduce symptoms of the disorder without the
Die US-Zulassungsbehörde FDA hat das Medikament von AstraZeneca zur Behandlung solider Tumore zugelassen
The US Food and Drug Administration has granted accelerated approval for the expanded use of Daiichi Sankyo and AstraZeneca’s drug to treat patients with solid
Die US-amerikanische FDA hat das Antibiotikum Basilea Pharmaceutica zugelassen
Die US-Gesundheitsbehörde FDA hat das Antibiotikum von Basilea Pharmaceutica zur Behandlung bakterieller Infektionen, darunter auch multiresistenter Stämme, zugelassen, teilte die Behörde am Mittwoch mit.
Mitsui und Rohto kaufen chinesisches Pharmaunternehmen Eu Yan Sang für $594m
Japan’s Mitsui & Co said on Thursday it has teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing